Related references
Note: Only part of the references are listed.Pharmacokinetics and Tumor Disposition of PEGylated, Methotrexate Conjugated Poly-L-lysine Dendrimers
Lisa M. Kaminskas et al.
MOLECULAR PHARMACEUTICS (2009)
Synthesis and In Vivo Antitumor Efficacy of PEGylated Poly(L-lysine) Dendrimer-Camptothecin Conjugates
Megan E. Fox et al.
MOLECULAR PHARMACEUTICS (2009)
Combination of antiangiogenesis with chemotherapy for more effective cancer treatment
Jie Ma et al.
MOLECULAR CANCER THERAPEUTICS (2008)
Scheduling of radiation with angiogenesis inhibitors anginex and avastin improves therapeutic outcome via vessel normalization
Ruud P. M. Dings et al.
CLINICAL CANCER RESEARCH (2007)
Dendrimers as multi-purpose nanodevices for oncology drug delivery and diagnostic imaging
D. A. Tomalia et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2007)
Opinion - Angiogenesis: an organizing principle for drug discovery?
Judah Folkman
NATURE REVIEWS DRUG DISCOVERY (2007)
PEGylated lysine dendrimers for tumor-selective targeting after intravenous injection in tumor-bearing mice
Tatsuya Okuda et al.
JOURNAL OF CONTROLLED RELEASE (2006)
Cationic poly-L-lysine dendrimers: Pharmacokinetics, biodistribution, and evidence for metabolism and bioresorption after intravenous administration to rats
Ben J. Boyd et al.
MOLECULAR PHARMACEUTICS (2006)
An intrinsically fluorescent dendrimer as a nanoprobe of cell transport
Khuloud T. Al-Jamal et al.
JOURNAL OF DRUG TARGETING (2006)
Dendrimers in gene delivery
C Dufès et al.
ADVANCED DRUG DELIVERY REVIEWS (2005)
Dendrimer delivery of an anti-VEGF oligonucleotide into the eye: a long-term study into inhibition of laser-induced CNV, distribution, uptake and toxicity
RJ Marano et al.
GENE THERAPY (2005)
Nanoparticle targeting of anticancer drug improves therapeutic response in animal model of human epithelial cancer
JF Kukowska-Latallo et al.
CANCER RESEARCH (2005)
Intravital imaging of tumour vascular networks using multi-photon fluorescence microscopy
GM Tozer et al.
ADVANCED DRUG DELIVERY REVIEWS (2005)
Murine endothelial cell lines as models of tumor endothelial cells
J Walter-Yohrling et al.
CLINICAL CANCER RESEARCH (2004)
Polyvalent dendrimer glucosamine conjugates prevent scar tissue formation
S Shaunak et al.
NATURE BIOTECHNOLOGY (2004)
Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer
H Hurwitz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Inhibition of in vitro VEGF expression and choroidal neovascularization by synthetic dendrimer peptide mediated delivery of a sense oligonucleotide
RJ Marano et al.
EXPERIMENTAL EYE RESEARCH (2004)
Efficacy of dendrimer-mediated angiostatin and TIMP-2 gene delivery on inhibition of tumor growth and angiogenesis:: In vitro and in vivo studies
L Vincent et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
The antiangiogenic and therapeutic implications of endostatin
B Ren et al.
METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY (2003)
Designing macromolecules for therapeutic applications:: Polyester dendrimer-poly(ethylene oxide) bow-tie hybrids with tunable molecular weight and architecture
ER Gillies et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2002)
Tumor microvascular changes to anti-angiogenic treatment assessed by MR contrast media of different molecular weights
TPL Roberts et al.
ACADEMIC RADIOLOGY (2002)
Design and synthesis of antiangiogenic/heparin-binding arginine dendrimer mimicking the surface of endostatin
S Kasai et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2002)
Polylysine as a vehicle for extracellular matrix-targeted local drug delivery, providing high accumulation and long-term retention within the vascular wall
DV Sakharov et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2001)
Tumor angiogenesis: past, present and the near future
RS Kerbel
CARCINOGENESIS (2000)
Share Paper
